Triclabendazole
CAS 68786-66-3 2 FDA-DMF suppliersSmall Molecule
Overview
Triclabendazole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1086440).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Triclabendazole expires — and exclusivity 13 Feb 2026. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzimidazole
- Canonical SMILES
- CSC1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl
- InChIKey
- NQPDXQQQCQDHHW-UHFFFAOYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.